Tatiana Bremova-Ertl Selected Research

acetylleucine

3/2022	Efficacy and safety of N-acetyl-L-leucine in Niemann-Pick disease type C.
1/2022	Effects of Acetyl-DL-Leucine on Ataxia and Downbeat-Nystagmus in Six Patients With Ataxia Telangiectasia.
1/2021	Acetyl-leucine slows disease progression in lysosomal storage disorders.
12/2020	Sandhoff Disease: Improvement of Gait by Acetyl-DL-Leucine: A Case Report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatiana Bremova-Ertl Research Topics

Disease

4	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 03/2022 - 07/2020
2	Ataxia (Dyssynergia) 01/2022 - 01/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2021 - 01/2021
2	Disease Progression 01/2021 - 01/2018
2	Sandhoff Disease (Sandhoff's Disease) 01/2021 - 12/2020
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022
1	Splenomegaly 06/2021
1	Dystonia (Limb Dystonia) 06/2021
1	Motor Neuron Disease (Primary Lateral Sclerosis) 06/2021
1	Gaucher Disease (Gaucher's Disease) 06/2021
1	Parkinsonian Disorders (Parkinsonism) 06/2021
1	Dementia (Dementias) 06/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Vertigo (Positional Vertigo) 01/2021
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2021
1	GM2 Gangliosidoses (GM2 Gangliosidosis) 01/2021
1	Ganglion Cysts (Ganglion) 07/2020
1	Retinal Degeneration 07/2020

Drug/Important Bio-Agent (IBA)

4	acetylleucineIBA 03/2022 - 12/2020
2	Leucine (L-Leucine)FDA Link 01/2021 - 01/2021
1	Filipin (Filipin III)IBA 06/2021
1	Glucosylceramidase (Glucocerebrosidase)IBA 06/2021
1	Levodopa (L Dopa)FDA LinkGeneric 06/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	LipidsIBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	Retinaldehyde (Retinal)IBA 07/2020

Therapy/Procedure

2	Therapeutics 06/2021 - 01/2018
1	Off-Label Use 01/2021
1	Treatment Delay 01/2021